As of 2026-03-23, the EV/EBITDA ratio of Charles River Laboratories International Inc (CRL) is 10.23. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CRL's latest enterprise value is 9,487.71 mil USD. CRL's TTM EBITDA according to its financial statements is 927.19 mil USD. Dividing these 2 quantities gives us the above CRL EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 12.0x - 14.3x | 12.1x |
| Forward P/E multiples | 12.8x - 19.8x | 16.0x |
| Fair Price | 75.65 - 230.58 | 147.25 |
| Upside | -50.7% - 50.1% | -4.1% |
| Date | EV/EBITDA |
| 2026-03-20 | 10.23 |
| 2026-03-19 | 10.20 |
| 2026-03-18 | 10.42 |
| 2026-03-17 | 10.24 |
| 2026-03-16 | 10.15 |
| 2026-03-13 | 10.33 |
| 2026-03-12 | 10.18 |
| 2026-03-11 | 11.05 |
| 2026-03-10 | 10.96 |
| 2026-03-09 | 11.47 |
| 2026-03-06 | 11.34 |
| 2026-03-05 | 11.70 |
| 2026-03-04 | 11.61 |
| 2026-03-03 | 11.41 |
| 2026-03-02 | 11.56 |
| 2026-02-27 | 11.55 |
| 2026-02-26 | 11.39 |
| 2026-02-25 | 10.97 |
| 2026-02-24 | 10.89 |
| 2026-02-23 | 10.76 |
| 2026-02-20 | 11.05 |
| 2026-02-19 | 10.80 |
| 2026-02-18 | 10.47 |
| 2026-02-17 | 10.49 |
| 2026-02-13 | 10.64 |
| 2026-02-12 | 10.51 |
| 2026-02-11 | 10.89 |
| 2026-02-10 | 11.70 |
| 2026-02-09 | 11.94 |
| 2026-02-06 | 12.12 |
| 2026-02-05 | 11.83 |
| 2026-02-04 | 12.78 |
| 2026-02-03 | 12.77 |
| 2026-02-02 | 13.40 |
| 2026-01-30 | 13.25 |
| 2026-01-29 | 13.32 |
| 2026-01-28 | 13.59 |
| 2026-01-27 | 13.73 |
| 2026-01-26 | 13.88 |
| 2026-01-23 | 13.74 |
| 2026-01-22 | 13.97 |
| 2026-01-21 | 14.12 |
| 2026-01-20 | 13.66 |
| 2026-01-16 | 13.74 |
| 2026-01-15 | 13.94 |
| 2026-01-14 | 13.57 |
| 2026-01-13 | 13.70 |
| 2026-01-12 | 13.70 |
| 2026-01-09 | 13.81 |
| 2026-01-08 | 13.52 |